[RGLS] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
14-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -21.34%
YoY- -82.12%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 5,000 5,000 0 6 18 18 18 4085.29%
PBT -1,315 -1,523 -6,947 -5,945 -4,893 -5,423 -5,015 -58.86%
Tax 7 1 10 -8 -131 87 1 263.77%
NP -1,322 -1,524 -6,947 -5,937 -4,893 -5,423 -5,016 -58.72%
Tax Rate - - - - - - - -
Total Cost 6,322 6,524 6,947 5,943 4,911 5,441 5,034 16.32%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -26.44 -30.48 0.00 -98,950.00 -27,183.33 -30,127.78 -27,866.67 -99.01%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.28 -0.40 -2.33 -2.47 -2.34 -2.60 -3.00 -79.27%
EPS Diluted -0.28 -0.40 -2.33 -2.47 -2.34 -2.60 -3.00 -79.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.